Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
1.911
-0.039 (-2.02%)
Mar 31, 2025, 10:32 AM EDT - Market open

Intensity Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
6.093.532.422.161.17
Upgrade
Research & Development
10.54.795.135.865.05
Upgrade
Operating Expenses
16.598.327.558.016.22
Upgrade
Operating Income
-16.59-8.32-7.55-8.01-6.22
Upgrade
Interest Expense
--0.31-0.08--
Upgrade
Interest & Investment Income
0.310.32000.07
Upgrade
Other Non Operating Income (Expenses)
00.020.050.120.12
Upgrade
EBT Excluding Unusual Items
-16.27-8.28-7.58-7.9-6.03
Upgrade
Other Unusual Items
--2.26---
Upgrade
Pretax Income
-16.27-10.54-7.58-7.9-6.03
Upgrade
Net Income
-16.27-10.54-7.58-7.9-6.03
Upgrade
Preferred Dividends & Other Adjustments
-1.32---
Upgrade
Net Income to Common
-16.27-11.86-7.58-7.9-6.03
Upgrade
Shares Outstanding (Basic)
149333
Upgrade
Shares Outstanding (Diluted)
149333
Upgrade
Shares Change (YoY)
61.40%152.67%-0.02%0.19%
Upgrade
EPS (Basic)
-1.17-1.38-2.22-2.32-1.77
Upgrade
EPS (Diluted)
-1.17-1.38-2.22-2.32-1.77
Upgrade
EBIT
-16.59-8.32-7.55-8.01-6.22
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q